{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:30:09Z","timestamp":1767997809035,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00125-015-3613-9","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T15:47:11Z","timestamp":1431532031000},"page":"1868-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice"],"prefix":"10.1007","volume":"58","author":[{"given":"Tadasuke","family":"Komori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"3613_CR1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821\u20131830","journal-title":"J Clin Invest"},{"key":"3613_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2008.08.015","volume":"8","author":"D Patsouris","year":"2008","unstructured":"Patsouris D, Li P-P, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301\u2013309","journal-title":"Cell Metab"},{"key":"3613_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363\u2013374","journal-title":"Nat Med"},{"key":"3613_CR4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J-P Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J-P, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881\u2013887","journal-title":"Nature"},{"key":"3613_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.physbeh.2007.11.049","volume":"94","author":"NA Herpen van","year":"2008","unstructured":"van Herpen NA, Schrauwen-Hinderling VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94:231\u2013241","journal-title":"Physiol Behav"},{"key":"3613_CR6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","volume":"56","author":"B Sun","year":"2012","unstructured":"Sun B, Karin M (2012) Obesity, inflammation, and liver cancer. J Hepatol 56:704\u2013713","journal-title":"J Hepatol"},{"key":"3613_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu G-Y et al (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197\u2013208","journal-title":"Cell"},{"key":"3613_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10254-003-0013-1","volume":"149","author":"M Tanaka","year":"2003","unstructured":"Tanaka M, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39\u201352","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"3613_CR9","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1128\/MCB.18.6.3357","volume":"18","author":"RA Lindberg","year":"1998","unstructured":"Lindberg RA, Juan TSC, Welcher AA et al (1998) Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 18:3357\u20133367","journal-title":"Mol Cell Biol"},{"key":"3613_CR10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood.V93.3.804","volume":"93","author":"M Tanaka","year":"1999","unstructured":"Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A (1999) Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor \u03b2 subunit. Blood 93:804\u2013815","journal-title":"Blood"},{"key":"3613_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/dvdy.10156","volume":"225","author":"S Tamura","year":"2002","unstructured":"Tamura S, Morikawa Y, Miyajima A, Senba E (2002) Expression of oncostatin M in hematopoietic organs. Dev Dyn 225:327\u2013331","journal-title":"Dev Dyn"},{"key":"3613_CR12","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1523\/JNEUROSCI.22-13-05334.2002","volume":"22","author":"P Repovic","year":"2002","unstructured":"Repovic P, Benveniste EN (2002) Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22:5334\u20135343","journal-title":"J Neurosci"},{"key":"3613_CR13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.jid.5700136","volume":"126","author":"I Goren","year":"2006","unstructured":"Goren I, K\u00e4mpfer H, M\u00fcller E, Schiefelbein D, Pfeilschifter J, Frank S (2006) Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126:628\u2013637","journal-title":"J Invest Dermatol"},{"key":"3613_CR14","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1074\/jbc.M113.461905","volume":"288","author":"T Komori","year":"2013","unstructured":"Komori T, Tanaka M, Senba E, Miyajima A, Morikawa Y (2013) Lack of oncostatin M receptor \u03b2 leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. J Biol Chem 288:21861\u201321875","journal-title":"J Biol Chem"},{"key":"3613_CR15","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1074\/jbc.M113.542399","volume":"289","author":"T Komori","year":"2014","unstructured":"Komori T, Tanaka M, Senba E, Miyajima A, Morikawa Y (2014) Deficiency of oncostatin M receptor \u03b2 (OSMR\u03b2) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. J Biol Chem 289:13821\u201313837","journal-title":"J Biol Chem"},{"key":"3613_CR16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1096\/fj.11-202853","volume":"26","author":"HW Kang","year":"2012","unstructured":"Kang HW, Niepel MW, Han S et al (2012) Thioesterase superfamily member 2\/acyl-CoA thioesterase 13 (Them2\/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J 26:2209\u20132221","journal-title":"FASEB J"},{"key":"3613_CR17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK\u03b2. Science 293:1673\u20131677","journal-title":"Science"},{"key":"3613_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"3613_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","volume":"159","author":"AB Goldfine","year":"2013","unstructured":"Goldfine AB, Fonseca V, Jablonski KA et al (2013) Salicylate (Salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med 159:1\u201312","journal-title":"Ann Intern Med"},{"key":"3613_CR20","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/ATVBAHA.107.148429","volume":"27","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Abidi P, Kim A et al (2007) Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin M reduces hypertriglyceridemia through enhanced \u03b2-oxidation. Arterioscler Thromb Vasc Biol 27:2198\u20132205","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3613_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","volume":"1044","author":"CR Abbott","year":"2005","unstructured":"Abbott CR, Monteiro M, Small CJ et al (2005) The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044:127\u2013131","journal-title":"Brain Res"},{"key":"3613_CR22","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","volume":"146","author":"T Talsania","year":"2005","unstructured":"Talsania T, Anini Y, Siu S et al (2005) Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology 146:3748\u20133756","journal-title":"Endocrinology"},{"key":"3613_CR23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941\u2013946","journal-title":"Nat Med"},{"key":"3613_CR24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C et al (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58:250\u2013259","journal-title":"Diabetes"},{"key":"3613_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91\u2013100","journal-title":"J Clin Invest"},{"key":"3613_CR26","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher FM, Chui PC, Antonellis PJ et al (2010) Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59:2781\u20132789","journal-title":"Diabetes"},{"key":"3613_CR27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","volume":"17","author":"Z Lin","year":"2013","unstructured":"Lin Z, Tian H, Lam KSL et al (2013) Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17:779\u2013789","journal-title":"Cell Metab"},{"key":"3613_CR28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","volume":"17","author":"WL Holland","year":"2013","unstructured":"Holland WL, Adams AC, Brozinick JT et al (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17:790\u2013797","journal-title":"Cell Metab"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-015-3613-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3613-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T04:16:18Z","timestamp":1599020178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-015-3613-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3613"],"URL":"https:\/\/doi.org\/10.1007\/s00125-015-3613-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}